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Structural biology now plays a prominent role in addressing questions central to understanding how
excitable cells function. Although interest in the insights gained from the definition and dissection of
macromolecular anatomy is high, many neurobiologists remain unfamiliar with the methods
employed. This primer aims to help neurobiologists understand approaches for probing macro-
molecular structure and where the limits and challenges remain. Using examples of macromolecules
with neurobiological importance, the review covers X-ray crystallography, electronmicroscopy (EM),
small-angle X-ray scattering (SAXS), and nuclear magnetic resonance (NMR) and biophysical
methods with which these approaches are often paired: isothermal titration calorimetry (ITC),
equilibrium analytical ultracentifugation, and molecular dynamics (MD).Introduction
Since the time of Ramon y Cajal, neurobiologists have ap-
preciated the value in understanding the intimate connec-
tion between the structure and function of biological sys-
tems. The power to visualize the architecture of different
types of neurons in the brain has been indispensable for
deciphering the inner workings of what may be the most
complex biological system in the universe. More recently,
the importance of architecture at a different scale has
emerged in addressing questions that are central to how
neurons function, the anatomy of macromolecules. In par-
ticular, it is the anatomy of proteins such as ion channels,
cell surface receptors, transporters, pumps, and synaptic
proteins that has grabbed neurobiologists’ attention.
While there is great interest in the information revealed
by structural biology, many neurobiologists are likely to
be unfamiliar with the details of the approaches, the inter-
pretation of the data, and most importantly, the limitations
of the biophysical methods used to define and dissect
macromolecular structure. The determination of a macro-
molecular structure empowers one to understand and af-
fect biological processes in a way that is unparalleled and
brings clarity to diverse lines of investigation that range
from mechanistic studies to drug development. In light
of the revelatory nature of macromolecular structures,
this primer aims to help the structural biology novice un-
derstand the basics of protein structure determination
so that he or she can critically assess the published data
and, more importantly, understand how to employ the re-
sults in his or her own research.
The discipline of structural biology has origins in the
same half of the 20th century that brought the initial under-
standing of action potentials (Dickerson, 2005; Perutz,1997). The transforming notion was that biology is molec-
ular at its root and must be understood in the language of
molecules and physical chemistry (Dickerson, 2005). De-
spite the permeation of this notion into all domains of bio-
logical science, the real power of structural approaches
for addressing questions of central importance to neuro-
science only emerged in the late 1990s. This delay was
not due to a lack of desire or appreciation of the power
of the approach, but rather to practical matters. Many of
the macromolecules that interest neurobiologists reside
in or work at the cell membrane and may exist in very lim-
ited numbers in a cell. Such molecules carry special chal-
lenges. From cloning to structural studies, many steps in
understanding them at the molecular level have come
late relative to progress in other areas of biology such as
DNA replication and transcription. The recent accelerated
progress and increasing number of high-resolution struc-
tural models for molecules with direct importance for neu-
roscience (Table 1) offers an opportune moment to outline
how the beautiful molecular structures are uncovered,
what they tell us about function, and why understanding
macromolecular structure brings deep insight that has im-
plications for questions asked in areas that range from
protein biophysics to neurological disease.
Why Structures?
Proteins are linear amino acid heteropolymers that have
an exact amino acid sequence defined by the gene se-
quence. The amino acid sequence determines the 3D pro-
tein structure, the integrity of which is absolutely essential
to its function (Petsko and Ringe, 2003). The transforma-
tion of information from the one-dimensional (1D) amino
acid sequence into a 3D structure with properties thatNeuron 54, May 24, 2007 ª2007 Elsevier Inc. 511
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Resolutiona Reference
Ligand-gated ion channels:
whole channels
Torpedo marmorata nicotinic
acetylcholine receptor
4.0 A˚ Miyazawa et al., 2003
Ligand-gated ion channels:
extracellular domains
Mollusc AChBPs
Limnea stagnalis AChBP 2.7 A˚ Brejc et al., 2001
Limnea stagnalis AChBP:
conotoxin complex
2.4 A˚ Celie et al., 2005a
Limnea stagnalis AChBP:
carbamoylcholine and
nicotine complexes
2.2 A˚ Celie et al., 2004
Glutamate receptors:
extracellular domains
AMPA (GluR2) 1.9 A˚ Armstrong et al., 1998
AMPA (GluR2): agonist, antagonist,
and modulator complexes
2.1 A˚ Sun et al., 2002
Kainate R (GluR5): antagonist
complexes
1.74 A˚ Mayer et al., 2006
Kainate R (GluR6): agonist complexes 1.65 A˚ Mayer, 2005a
NMDAR (NR1/NR2A heteromer) 1.88 A˚ Furukawa et al., 2005
Potassium channels:
whole channels
Rat Kv1.2/Kvb complex 2.9 A˚ Long et al., 2005
Archaeal voltage-gated
channel KvAP
3.2 A˚ Jiang et al., 2003
Bacterial potassium channel: KcsA 2.0 A˚ Zhou et al., 2001
Bacterial potassium channel MthK 3.3 A˚ Jiang et al., 2002
Bacterial inward rectifier KirBac1.1 3.65 A˚ Kuo et al., 2003
Bacterial nonselective cation
channel NaK
2.4 A˚ Shi et al., 2006
Potassium channel intracellular
domains and regulatory complexes
Kv4.3/KChIP1 complex 3.2 A˚ Pioletti et al., 2006;
Wang et al., 2007
Kir3.1 intracellular domain 1.8 A˚ Nishida and MacKinnon, 2002
HERG PAS domain 2.6 A˚ Morais Cabral et al., 1998
SK channel intracellular domain:
Ca2+/CaM complex
1.6 A˚ Schumacher et al., 2001
Voltage-gated calcium channels:
intracellular domains
CaVb and CaVb-AID complex 2.0 A˚ Chen et al., 2004;
Opatowsky et al., 2004;
Van Petegem et al., 2004
Ca2+/CaM-CaV1.2 IQ domain
complex
2.0 A˚ Fallon et al., 2005;
Van Petegem et al., 2005
Cyclic nucleotide gated channels HCN2 Cyclic nucleotide binding
domain/cAMP
2.0 A˚ Zagotta et al., 2003
HCN2 Cyclic nucleotide binding
domain/cGMP
1.9 A˚ Zagotta et al., 2003
TRP Channels N-terminal Ankyrin repeat
domain TRPV2
1.6 A˚ Jin et al., 2006;
McCleverty et al., 2006
TRPM7 kinase domain 2.4 A˚ Yamaguchi et al., 2001
Chloride channels: whole channel Bacterial chloride channel 3.0 A˚ Dutzler et al., 2002
Chloride channel intracellular
domains
Human ClC-5 CBS domain
(ATP and ADP)
2.3 A˚ Meyer et al., 2007512 Neuron 54, May 24, 2007 ª2007 Elsevier Inc.
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Resolutiona Reference
Ca2+ ATPase No nucleotide, with calcium 2.6 A˚ Toyoshima et al., 2000
Magnesium fluoride 2.3 A˚ Toyoshima et al., 2004
G protein-coupled receptors Rhodopsin 2.8 A˚ Palczewski et al., 2000
G protein-coupled receptors:
extracellular domains
mGluR1 ligand binding domain:
apo and gluatmate complex
2.2 A˚ Kunishima et al., 2000
mGluR1 ligand binding domain:
antagonist complex
3.3 A˚ Tsuchiya et al., 2002
Amino acid transporters Archaeal glutamate transporter 3.5 A˚ Yernool et al., 2004
Archaeal asparate transporter 1.65 A˚ Yamashita et al., 2005
a Where multiple similar structures are solved, the highest resolution obtained is indicated.are defined in space and time animates genomic informa-
tion into the cellular components that give living systems
their unique properties. Because of this central link, struc-
ture determination reveals an unparalleled view into the
design principles of living systems at levels that span
from basic mechanistic questions regarding protein func-
tion to the evolutionary relationships between cellular
components.
How is it then that one transforms the idea of determin-
ing a protein structure into the achievement of determining
an actual structure? Here, I outline the basic methods
used to derive structural information. These include
X-ray crystallography, electron microscopy (EM), small-
angle X-ray scattering (SAXS), and nuclear magnetic
resonance (NMR) spectroscopy (Table 2), as well as the
protein biophysical tools with which they are frequently
paired (titration calorimetry, analytical ultracentrifugation,
and molecular dynamics [MD]). For each case I consider
the advantages, disadvantages, and points of technical
challenge. I treat the X-ray crystallographic approach in
greater depth because it routinely yields the highest-reso-
lution data and is likely to remain the most prominent
approach. Throughout the primer I have picked illustrative
examples from different areas of neuroscience, but given
the wide range of relevant structures now available, it is
impossible to be comprehensive. There is a bias toward
ion channel examples that only reflects the author’s area
of greatest familiarity and the fact that this area has seen
a great deal of recent, notable advances.
X-Ray Crystallography: From Idea to Structure
X-ray crystallography has unsurpassed power to resolve
the 3D configuration of amino acids within proteins and
protein complexes and is the only method that can rou-
tinely reach atomic resolution. Figure 1 shows a flow chart
of the basic steps. Technological advances have brought
many improvements to instrumentation, sample prepara-
tion, data collection, and data processing strategies; how-
ever, the central methods and mathematical approaches
that were developed to solve the first protein structures,
myoglobin and hemoglobin (Dickerson, 2005; Perutz,1997), still form the core of the methodology that is in use
today. The prerequisite for determining a protein structure
by X-ray crystallography is a good supply of crystals of the
protein or protein complex of interest. Thus, the first thing
to consider is how to crystallize a protein.
The Importance of Being a Good Biochemist
To make a serious attempt at crystallization, or, for that
matter, any of the structural methods outlined in this
primer, one needs to have a reasonable amount of pure
protein. What do ‘‘reasonable’’ and ‘‘pure’’ mean to a
structural biologist? A good-sized protein crystal for struc-
ture determination (0.2 mm 3 0.2 mm 3 0.2 mm) has
1013 molecules (1 mg of protein if the crystallized pro-
tein is 50 kDa). Like many things in life, more is better.
The more material one has, the easier it is to purify and
the more diverse the conditions are that can be searched
for crystallization. In order to define crystallization condi-
tions and grow crystals for structure determination, one
would ideally like to have at least 2 mg or more of pure pro-
tein or protein complex concentrated to 5–30 mg ml1.
The requirement for obtaining such quantities of material
remains one of the major hurdles in structure determina-
tion. This restriction is a dominant reason why structural
studies of proteins of particular interest to neuroscientists,
such as ion channels, receptors, and transporters, remain
great challenges. Presently, there are 40,000 unique
structures of soluble proteins in the protein database (Ber-
man et al., 2000). Contrast that number with the 100
membrane protein structures, of which only 12 are of eu-
karyotic origin (White, 2007; Striebeck, 2006), and one
gets a sense of how much we still need to learn about
membrane proteins.
In the early days of protein crystallographic studies, pro-
tein crystallographers worked on proteins that could be
obtained in large quantities from natural sources, usually
from cow and pig organs and blood procured from local
slaughterhouses. The advances in molecular cloning in
the 1980s and 1990s precipitated an important change:
newly developed bacterial expression systems, princi-
pally those using E. coli, allowed the structural biologistNeuron 54, May 24, 2007 ª2007 Elsevier Inc. 513
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Atomic
resolution
possible?
Typical
resolution
ranges Size ranges
Resolvable
features Limitations
Minimal
amount
of sample
required
Dynamic
information
X-ray
diffraction
yes 1.5–4 A˚ from short
peptides
to MDa
complexes
and
icosahedral
viruses
atoms,
secondary,
tertiary, and
quaternary
structure
requires
crystals,
stringent
purity
100–500 ml of
5–30 mg ml1
ordered versus
disordered
regions
Single-
particle EM
no negative stain
limited to
20 A˚;
particles in
ice, 10 A˚
proteins
>250 kD
(negative
stain); >400 kD
(particles in ice)
domain
organization
limited
resolution
100 ml of
0.1 mg ml1
can image
multiple
conformations
from one
sample
Electron
diffraction
yes 1.5–7 A˚ 15–250 kD atoms,
secondary,
tertiary, and
quaternary
structure
requires
2D crystals
or helical
tubes
100 ml of
1 mg ml1
ordered versus
disordered
regions
SAXS no 10–20 A˚ 10 kD to
0.6 MDa
domain
organization
limited
resolution
100 ml of
5–30 mg ml1
no
NMR Yes 1.5–3 A˚ for
backbone
atoms
limited to
<40 kDa
atoms,
secondary,
tertiary, and
quaternary
structure
sample
molecular
weight
100–500 ml of
5–30 mg ml1
atom-specific
dynamics
can be
measuredto produce proteins that had once been extremely rare in
native sources in the quantities required for structural
work. It is now routine for structural biology projects to
start with the definition of a good heterologous expression
system that can produce large amounts of properly folded
target protein. The power of genetic engineering that ac-
companies the use of heterologous expression systems
provides the researcher with exquisite control over the
precise boundaries of the construct under investigation
and permits the inclusion of a wide range of special, cleav-
able, high-affinity tags, such as polyhistidine tags, that
facilitate purification (Waugh, 2005). Presently, E. coli re-
mains the expression system of choice because of its
relative ease in handling, rapid growth, and low cost
(Georgiou and Segatori, 2005; Terpe, 2006). Many types
of bacterial expression plasmids have been developed
and are readily obtained from major molecular biology
suppliers such as Novagen and Invitrogen.
Many eukaryotic proteins cannot be made in bacterial
systems in a functional form, particularly if the protein of
interest requires some type of posttranslational modifi-
cation, such as glycosylation, for proper folding and
function. In some cases, it is possible to denature the
misfolded protein and define conditions that permit the
protein of interest to refold to into its native form; however,
it is preferable to start with a protein that has folded into its514 Neuron 54, May 24, 2007 ª2007 Elsevier Inc.native state in the host cell. As structural biologists get
more interested in protein complexes, membrane pro-
teins, and other difficult proteins, they are turning to
eukaryotic systems as an alternative means of protein pro-
duction (Aricescu et al., 2006a). Yeasts (S. cerevisae
[Jidenko et al., 2005] and P. pastoris [Daly and Hearn,
2005; Macauley-Patrick et al., 2005]), insect cells
(Aricescu et al., 2006a; Berger et al., 2004; Kost et al.,
2005), and mammalian cells (Aricescu et al., 2006b) have
all been used to make proteins for crystallization. Even
though the expense is much greater than bacterial sys-
tems, there is a growing appreciation of the benefit of ex-
pressing a protein in a more native host (i.e., expressing
eukaryotic proteins in eukaryotic cells) often being worth
the extra cost and effort. The main disadvantage with all
of the eukaryotic systems is that the turn-around time for
testing constructs and redesigning the expression exper-
iment (Figure 1, step A) is much longer than with bacterial
systems due to the increased length of time required for
cell growth and selection of transformants. Generally,
a few weeks to a month are required to go from gene to
protein in eukaryotic expression systems.
Besides giving careful consideration to the expression
system, it is considered a wise strategy to begin a struc-
ture project by testing many isoforms, homologs, and var-
iants of the protein or protein complex of interest in parallel
Neuron
PrimerFigure 1. Idea to Structure Flowchart
Basic steps of the process in solving a protein
X-ray crystal structure are shown. Gray arrows
show processes that are often iterated. (Step
A) Optimization of constructs following out-
come of expression tests. (Step B) Test of
different expression hosts. (Step C) Crystal
growth screening. (Step D) Crystal growth op-
timization. (Step E) Construct optimization to
improve crystals. (Steps F and F1) Construct
optimization to improve diffraction; (step F2),
search for new crystallization or cryoprotectant
conditions; (step F3) heavy atom soaks. (Step
G) Production of selenomethionine-labeled
protein for MAD and SAD experiments. (Step
H) Building and refinement cycle for refining
structure.in the early stages. This approach is beneficial because
there is no way to predict which proteins will express
well and purify cleanly. Small differences in amino acid
composition can make the difference between a well-be-
haved crystallizable protein and one that will never crystal-
lize. It involves more effort, but fortunately, the basic mo-
lecular biology and expression tests are easily done in
parallel. It is not unreasonable to expect one person to
make 10–100 constructs over the course of a week or
so. The parallel approach can be even more powerful if
one is able to test a few different expression systems
simultaneously for the same constructs as there is no good
way to predict the likelihood of success for any particular
one (Figure 1, step B).
Many proteins function only as parts of larger com-
plexes that are comprised of multiple types of subunits.
Protein complexes provide an added challenge for ex-
pression. In many cases, one or all of the components
may not fold properly if expressed in the absence of the
others. If it is not possible to isolate the complex in struc-
tural biology quantities from native sources, the only op-
tion is to make all the components at the same time in
the same expression host cell. As the interest in determin-
ing the structures of protein assemblies grows, there are
serious efforts to develop robust coexpression ap-proaches for bacterial and eukaryotic expression hosts
(Fitzgerald et al., 2006; Romier et al., 2006). Such coex-
pression approaches have already proven essential for
making the material for crystallographic study of a number
of ion channel complexes (Long et al., 2005; Pioletti et al.,
2006; Van Petegem et al., 2005; Wang et al., 2007). One
serious challenge posed by complexes is that the number
of variables to be tested increases with each protein com-
ponent. One has many choices about which subunit com-
binations to coexpress and whether each needs to be op-
timized to find a biochemically well-behaved construct.
The combinatorial nature of this problem leaves a pressing
need to develop better cloning schemes that allow the fac-
ile mixing and matching of potential interaction partners
and rapid testing for proper expression.
It is not just quantity, but also quality of material that is
important for crystallization. Ideally, the crystallization
subject must be chemically pure (McPherson, 1999).
There should be one and only one type of macromolecule
or complex in the tube. It should be folded into its native
conformation and not contain covalent heterogeneity
such as heterogeneous glycosylation or phosphorylation
and mixtures of truncation products. Chemical purity
can be assessed by gel electrophoresis, protein chroma-
tography, and mass spectrometry (Geerlof et al., 2006;Neuron 54, May 24, 2007 ª2007 Elsevier Inc. 515
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enough. The sample must also be conformationally pure.
Structural biologists typically will ask first whether the
crystallization subject is a single species in solution. This
is often done with size exclusion chromatography (see
below) or with light scattering measurements (Ferre-
D’Amare and Burley, 1994; Folta-Stogniew and Williams,
1999; Wen et al., 1996; Wilson, 2003) that can test whether
there are large aggregates or multiple aggregation states
in the sample. Such heterogeneity generally prohibits
crystallization and indeed can pose a serious problem
for all of the methods covered in this primer. Many proteins
have regions that are well ordered and regions that are not
well ordered, such as loops or disordered regions at the N
and C termini. This type of structural heterogeneity is
particularly common in eukaryotic proteins (Fink, 2005).
Disordered loops and termini can interfere with crystalliza-
tion. Bioinformatic analysis can be an important tool for
identifying such problematic regions (Prilusky et al.,
2005), as, generally, parts that are likely to be disordered
are also poorly conserved (Dale et al., 2003). The final
source of conformational heterogeneity may come from
the intrinsic properties of the protein itself. Proteins need
to move in order to function. Structural transitions can
range from small movements, on the order of a few ang-
stroms, to large conformational rearrangements that
may be driven by a wide range of factors, such as ligand
binding, voltage changes, or binding to a partner protein.
In this regard, the more one knows about the protein of in-
terest, the better. The inclusion of known substrates, bind-
ing partners, or inhibitors may be important for trapping
the protein in one particular conformational state for crys-
tallization. Conformational state trapping can also be done
by the introduction of mutations that lock the protein in
one state. This strategy was used successfully in the crys-
tallization of the sugar transporter lacY (Abramson et al.,
2003). Finally, the well-behaved ultrapure sample has to
be concentrated. A good rule of thumb is to get the protein
into the 5–30 mg ml1 range. In general, the more concen-
trated the sample is, the better. Every protein is different,
and not all subjects cooperate in the concentration step. If
one has a difficult protein to concentrate, the best one can
do is to make the sample as concentrated as possible and
try to crystallize it.
What Happens Once the Biochemist Has the
Tube Full of Purified, Concentrated Protein?
How Do You Make Crystals?
Protein crystallization is a phase transition that has dis-
crete steps of nucleation and growth (McPherson, 1999,
2004). The basic idea is to transfer the concentrated sam-
ple of the protein of interest into a solution of precipitants
that will encourage crystal formation. Precipitants act by
promoting the formation of intermolecular interactions,
and each particular precipitant has unique effects on mac-
romolecule hydration, molecular crowding, solubility, hy-
drophobic interactions, and electrostatics. Unfortunately,
solution components that encourage proteins to crystal-516 Neuron 54, May 24, 2007 ª2007 Elsevier Inc.lize are also prone to encourage the more common phe-
nomenon of simple, amorphous precipitation. It is impos-
sible to determine a priori which conditions, if any, will
cause a protein or protein complex to crystallize. Many
factors matter: precipitant type, pH, salt concentration,
detergents, temperature, the inclusion of cofactors and li-
gands, etc., and as a result, they define a vast amount of
chemical space that must be searched to find the right
crystallization conditions for each protein or complex. In
the face of a seemingly infinite number of variables paired
with a limited supply of purified protein or protein com-
plex, the only rational approach one can take is to screen
the effects of sets of parameters in a way that coarsely
samples the known sets of good protein crystallization
agents (McPherson, 1999). Typically, crystallization
screens focus on a limited set of concentrations of various
sizes of polyethylene glycols (PEGs), alcohols, and salts
that have been successful for protein crystallization in
the past (McPherson, 1999, 2004; Radaev et al., 2006).
The crystallization process is one of screening, optimiza-
tion, and reiteration (Figure 1, steps C and D). The imple-
mentation of commercial protein crystallization screens
such as those from Hampton Research, Wizard, and Nex-
tal, together with microcrystallization robotics, has made it
possible to test 1000 initial conditions routinely (Berry
et al., 2006; Stock et al., 2005). There is even the possibil-
ity of having the screening done for free or for a nominal
fee at a devoted protein crystallization center (HWI,
2007; Mueller-Dieckmann, 2006).
There are a variety of ways to set up the crystallization
experiment (McPherson, 1999, 2004). Vapor diffusion is
the most common approach. In this experiment the pro-
tein and precipitant are usually mixed in 1:1 proportion in
volumes from 50 nl to 1 ml, depending on the type of instru-
mentation used, and then placed in a sealed chamber that
contains a large volume relative to the drop of precipitant,
which is called the mother liquor solution. The ensuing im-
balance in vapor pressure slowly draws water from the
protein/precipitant drop into the mother liquor and con-
centrates the protein solution. For crystallization to occur
this process must lead to supersaturated protein solution,
a nonequilibrium condition in which the protein is tempo-
rarily in solution in excess of its solubility limit. Formation
of crystalline or amorphous precipitate reestablishes equi-
librium. Crystals may form within a few hours or may
require months, depending on the protein and particular
conditions.
In the best case, one finds conditions that yield large,
single crystals in the first crystallization screen. The
more probable outcome is that one finds small crystals,
crystalline material, just precipitate, or clear drops. The
first two cases provide some indication that it should be
possible to grow single crystals of the protein of interest.
If there are promising hits, crystallization conditions can
be refined by setting up secondary screens based on
a finer search of chemical space around the initial condi-
tions and by trying to improve the quality of the protein
preparation (Figure 1, steps C and D). For example, if
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over a pH range of 5–8, one might systematically vary
the PEG concentration from 10%–30% versus pH in a fol-
low-up screen or try other low molecular weight PEGs.
When no crystals or crystalline material is found, it is
best to follow the ‘‘don’t fall in love with a single protein’’
dictum and to go back to the biochemical stage to test
other constructs, homologs, and species variants (Fig-
ure 1, step E). The recognition that the protein is as impor-
tant a variable as anything else originates in the genesis of
the discipline when Perutz and Kendrew were trying to
crystallize hemoglobin and myoglobin from various organ-
isms (Perutz, 1997). The advantage of working with re-
combinant protein is that one has the power to make
many types of modifications. For instance, one might un-
dertake a systematic deletion of poorly conserved regions
that are likely candidates for disorder (Dale et al., 2003).
Membrane Proteins: Not Impossible,
but No Pain, No Gain
Membrane proteins are of particular importance to neuro-
scientists and the most challenging subject for structural
determination by crystallographic methods (Wiener,
2004). In large part, the crystallization challenges stem
from the following major issues: (1) Because the trans-
membrane part of the protein normally exists in a non-
aqueous environment, there are special requirements for
solubilizing the protein for purification and crystallization.
To address this issue, biochemists use a wide range of de-
tergents, only one or a few of which may work for a given
crystallization target. This extra requirement adds a new
complication and variation to the chemical space that
must be searched. (2) Obtaining the material in sufficient
quantities is a problem. Whether the protein is prokaryotic
or eukaryotic, routine overexpression of membrane pro-
teins remains a challenge (Wagner et al., 2006), and is par-
ticularly challenging for eukaryotic membrane proteins, of
which only three structures to date have been determined
from recombinantly produced material (Jidenko et al.,
2005; Long et al., 2005; Tornroth-Horsefield et al., 2006).
(3) There may be extra problems with context-dependent
conformational sensitivities that arise from the protein
being extracted from the constraints imposed by the
membrane. The most striking example of the influence
of the bilayer on conformation is at the heart of the recent
debate surrounding the relevance of the crystallographi-
cally observed conformation of the voltage sensor in the
bacterial voltage-gated potassium channel KvAP (Jiang
et al., 2003; Lee et al., 2005; Tombola et al., 2006). In spite
of all of these hurdles, membrane protein crystallization
and structure determination is certainly possible. It has
been more than 20 years since the first membrane protein
structure was reported (Deisenhofer et al., 1985). Three
websites keep up-to-date tallies of the latest membrane
protein structural information (White, 2007; Striebeck,
2006; Raman et al., 2006). In terms of crystallization strat-
egies for membrane proteins, there are some special
methods that use lipid phases for membrane protein crys-tallization (Faham and Bowie, 2002; Nollert et al., 2002),
but most of the successes to date have come from the ap-
plication of the traditional crystallization methods. There is
nothing impossible about crystallizing membrane pro-
teins. It is just extremely hard.
If one is interested in membrane proteins, is that scien-
tist confined to remain ignorant about the protein’s struc-
ture while toiling on the all-or-nothing path structure deter-
mination? Thankfully, the answer is ‘‘No.’’ One fruitful
shortcut is to exploit the property that many proteins are
modular. This underlying biological fact permits one to
dissect the problem by solving structures of extramem-
branous domains, which may be more readily dealt with
than the membrane resident parts, and use the structures
to inform functional experiments. This dissection ap-
proach is very powerful and has yielded great insights
into both metabotropic (Kubo and Tateyama, 2005) and
ionotropic (Mayer, 2005b) glutamate receptors, potas-
sium channels (Roosild et al., 2004), calcium channels
(Van Petegem and Minor, 2006), cyclic nucleotide gated
channels (Craven and Zagotta, 2006), acetylcholine re-
ceptors (Sixma and Smit, 2003), and a large collection of
cell surface receptors, such as neurotrophin receptors
(Wiesmann and de Vos, 2001), LDL receptors (Jeon
and Blacklow, 2005), and Nogo receptors (Vourc’h and
Andres, 2004).
With the notable exceptions of the Kv1.2 potassium
channel (Long et al., 2005) and the G protein-coupled re-
ceptor rhodopsin (Palczewski et al., 2000), the challenge
of seeing the transmembrane segments has been met to
date by turning to prokaryotic channels and transporters
(Gouaux and Mackinnon, 2005). These proteins are often
similar enough to their eukaryotic counterparts to reveal
the central architecture of the protein family of interest,
and are advantageous in that they are much more likely
to express in large quantities in a heterologous system.
Once You Have Crystals of Your Protein, Does that
Mean that Everything Is Straightforward?
The answer to this question is, unfortunately, ‘‘No!’’ A
crystal can only diffract X-rays to atomic, or near atomic,
resolution if it is ordered. Unlike mineral or small molecule
crystals, protein crystals are mostly water (30%–80%).
The lattice is held together by relatively weak interactions.
This property can lead to crystals that are fragile, have in-
ternal disorder, or both, and consequently diffract X-rays
poorly. There is no way to be certain from the outward ap-
pearance of the crystal. The only way to know is to put the
crystal in an X-ray beam and measure the diffraction pat-
tern. There are many textbooks that provide detailed de-
scriptions of protein crystallography; here, I will just try
to convey the basics of the method. For the reader inter-
ested in a more in-depth treatment, two good starting
points are the books by Gale Rhodes (Rhodes, 2006)
and David Blow (Blow, 2002).
In order to understand the basics of the X-ray diffraction
experiment, it is important to define a few terms about how
molecules are organized within the crystal latticeNeuron 54, May 24, 2007 ª2007 Elsevier Inc. 517
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same unit that are related to each other by simple transla-
tions in space. This repetitive unit is known as the unit cell.
There are fourteen different types of unit cells (for exam-
ple: cubes, prisms, and hexagons) in 3D crystals. Each
particular unit cell type imposes constraints on the lengths
and angles of the unit cell axes (Crystallography, 2002).
The unit cell may contain a single copy of the protein or
complex that has been crystallized, but more often than
not, it contains many copies of the protein or complex
that are related to each other by a set of rotations and
translations, defined as the crystallographic symmetry.
For protein crystals, there are 65 possible types of crystal-
lographic symmetry, although an individual crystal will
have only one type. For example, P222 denotes a space
group in which there are three mutually perpendicular
2-fold axes of symmetry. Application of the crystallo-
graphic symmetry operations to the asymmetric unit, the
fundamental repetitive unit of the unit cell (Figure 2A),
builds the unit cell (Figure 2B). It is the asymmetric unit
that the crystallographer determines in solving the struc-
ture. The asymmetric unit can be the biological unit, but
is often not when the biological unit is built from symmet-
Figure 2. Anatomy of a Protein Crystal
(A) Example of an asymmetric unit (AChBP). In this case the asymmet-
ric unit is the same as the biological unit.
(B) Crystallographic symmetry operators applied to the asymmetric
unit create the unit cell. Note that the AChBP pentamers in the upper
right and lower left corners of the cell are in the opposite orientation
of the orange pentamer.
(C) Translations of the unit cell build the protein crystal lattice.518 Neuron 54, May 24, 2007 ª2007 Elsevier Inc.rically positioned protein chains such as in a homodimer or
homotetramer. Upon publication, crystallographers de-
posit the coordinates that describe the asymmetric unit
in the protein data bank, where they are freely available
(Berman et al., 2000; http://www.pdb.org/, or PDB).
Many users of the structures now include biochemists or
cell biologists who may not be familiar enough with the
crystallographic programs to make the biological unit
from the deposited coordinates. Consequently, the PDB
has also taken to including files that contain the biological
unit. By the very nature of the crystal lattice, there have to
be protein-protein interactions to form the crystal. Such
contacts may reveal previously unappreciated interac-
tions; for example, symmetry operations within the crystal
may generate multimeric molecular assemblies. In all
cases it is important for the crystallographer to figure out
whether the apparent assembly and observed protein-
protein interactions reflect an authentic assembly with bi-
ological significance or are simply interactions that are
only critical for building the crystal lattice.
X-rays are electromagnetic waves that have short
wavelengths (angstroms, A˚). The use of X-rays is essential
because the features that need to be discerned are on the
order of angstroms (0.1 nm or 1010 m). For instance, the
covalent distance between atoms is 1–2 A˚ and the dis-
tance between hydrogen bonds donors and acceptors is
2.5–3.5 A˚. The best wavelength range for X-ray crystallog-
raphy involves X-rays having wavelengths between
0.5–1.6 A˚. These X-ray wavelengths are sufficient to pen-
etrate samples of up to 1 mm thick, but are still strongly
scattered by matter.
In contrast to the longer wavelengths of electromag-
netic radiation with which a neurobiologist might be famil-
iar, such as visible or near-ultraviolet light, it is not possible
to focus the X-rays that are used for seeing atoms with
a lens. This issue offers both a challenge and an advan-
tage for how macromolecular structures are determined.
In addition to wavelength, waves have two key properties,
amplitude and phase. What is measured in an X-ray
diffraction experiment is the intensity of the coherently
scattered X-rays. The diffraction pattern is an array of ‘‘re-
flections’’ in which the pattern and spacing is set by the
unit cell parameters (Figure 3). Each reflection carries in-
formation about the entire content of the asymmetric
unit. There is an inverse relationship between the position
of a reflection in a diffraction pattern and the resolution of
the information. Low-resolution information is found near
the center of the diffraction image, close to the position
of the incident beam, while high-resolution data are found
at larger scattering angles (Figure 3B). It is the presence
and quality of the high-resolution reflections that deter-
mines the resolution limits of a given experiment. These
limits are set by the quality of the internal order of the crys-
tal. Once the crystal parameters (space group and unit cell
size) are determined from the diffraction pattern, the crys-
tallographer knows exactly where all the reflections at any
resolution should be. Thus, it is straightforward to figure
out to which resolution the crystal diffracts. As the
Neuron
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Schematic
(A) Standard setup for data collection. The
protein crystal is mounted on a goniometer
(orange) and is frozen in a nylon loop. Incoming
nitrogen gas at 100K maintains the frozen state
of the crystal. X-rays emerge from a collimator
on the X-ray source.
(B) Diffracted X-rays are collected on a detec-
tor. An example of an X-ray diffraction pattern
is shown with low- and high-resolution data re-
gions indicated. In the actual setup, the detec-
tor face is normal to the X-rays.
(C) Example of an initial electron density map at
2.0 A˚ with phases determined by selenome-
thionine MAD. A helix can be seen prominently
on the right-hand side.
(D) Final refined model.scattered X-ray waves cannot be focused to reconstruct
the image, other methods must be used to generate the
phase information. Unlike the capture of an image on
a 2D surface, such as our retinas or film in a camera, the
fact that scattering from a crystal can be observed in all di-
rections means that the ensuing data really represents
a 3D image. It is not possible for one part of the protein
to obscure the view of another.
Cool Crystals
X-rays interact with the electrons in the sample, and when
absorbed, set the electrons vibrating at the incident X-ray
frequency. Two things can happen to this energy. A pho-
ton of the same energy and wavelength can be emitted in
a random direction (coherent scattering). Alternatively, the
absorbed energy may cause electronic transitions that re-
sult in the emission of one or more photons of lower en-
ergy (incoherent scattering). The first type of scattering
is necessary to measure X-ray diffraction. The second
causes radiation damage to the sample. Aside from the
need for an ordered lattice to produce a diffraction pattern
at high resolution, another reason for using crystals is that
the interactions between X-rays and matter can destroy
covalent bonds. The average crystal has 1013 copies
of the molecule to be imaged, so damage to any individual
copy is not so important. Successive damage and the
generation of reactive species can destroy many copies
in the lattice and lead to a degradation of the diffraction
signal. Such signal deterioration is unfortunately not un-
common, and often crystals diffract well at the beginning
of the experiment but lose diffraction power as the datacollection proceeds. As with other issues where proteins
are concerned, there is no way to know beforehand which
crystals will be radiation sensitive and which will not. For
these reasons, it is important to have more than one crys-
tal for the diffraction experiment.
Presently, most data collection is done at synchrotron
radiation sources. These X-ray sources provide a brilliant
source that helps crystallographers squeeze the most
data that they can out of their crystals. Most macromolec-
ular crystals lose the ability to diffract X-rays within a few
seconds of exposure to the high-intensity X-rays used at
synchrotron radiation sources; in order to preserve the
crystal from radiation damage, it must be flash frozen, usu-
ally at liquid nitrogen temperatures (Garman, 2003). The
gains are great in both crystal lifetime and quality of data
(Garman and Owen, 2006; Rodgers, 1994). It is estimated
that 90% of all macromolecular crystallographic data
collection is now done at 100K or lower (Garman and
Owen, 2006). Data collection is done in a cryostream of
nitrogen gas that keeps the crystal frozen throughout the
experiment (Figure 3A). The freezing procedure is fast
(milliseconds) (Kriminski et al., 2003) and is not likely to af-
fect protein conformation in any major way. If it did, it would
crack the crystal, and because the process is so fast it is
extremely unlikely that there could be synchronous, iden-
tical structural rearrangements in all of the proteins in the
lattice into some new conformation. Thus, even though
the temperature of the experiment is far from biological,
the protein conformation seen at the end of the structure
solution process is one that was abundant under the con-
ditions of the crystallization experiment. The fact that theNeuron 54, May 24, 2007 ª2007 Elsevier Inc. 519
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screening process. Freezing must happen without the for-
mation of ice crystals (which cause expansion and destroy
the order in the lattice) and under conditions in which the
water freezes as a glass. Thus, if the protein does not crys-
tallize in conditions that includes good cryoprotectants,
another search must be done in which the crystals are first
soaked in various cryoprotectants (such as glycerol, alco-
hols, or low molecular weight PEGs) and then frozen (Fig-
ure 1, step F2) (McPherson, 1999; Rodgers, 1994). For some
crystals, it is possible to transfer them into an oil, such as
paratone oil, and freeze them directly so that the search
for cryoprotectants is bypassed (McPherson, 1999).
Solutions to the Phase Problem
Electromagnetic waves are defined by a wavelength,
phase, and amplitude. The fact that only the scattered in-
tensities, which are related to the amplitude, of the X-rays
can be measured means that something has to be done to
get the information about the scattered X-rays’ phases.
This is known as the ‘‘phase problem’’ (Blow, 2002;
Drenth, 1999; Rhodes, 2006; Taylor, 2003). The only rela-
tionship between the reflection amplitudes and the
phases is through the molecular structure (formally, the
electron density in the crystal). Thus, if we can learn some-
thing about the electron density of the asymmetric unit, we
can obtain phase estimates and solve the structure.
There are three common ways employed to determine
phases. The first way, which was used to solve the first
protein structures in the 1960s, is to modify the protein
in the crystal with a ‘‘heavy atom’’ such as a mercury or
platinum complex. This is known as multiple isomorphic
replacement (MIR). Because proteins are made of light
atoms (C, H, O, N, S), the selective addition of a heavy
atom or atoms with a large number of electrons (for exam-
ple, Hg has 80 electrons) to precise binding sites on the
protein causes perturbations to the intensities of the re-
flections in the diffraction pattern. As long as the modifica-
tion does not alter the unit cell too much, a condition
known as isomorphism, the intensity perturbations can
be used to find the phases and locate the heavy atoms.
This location provides the phase estimate for refinement
and structure solution (see below). MIR requires a supply
of many crystals that can be screened for derivatives. Just
like the search for crystallization conditions, one does not
know a priori which derivatives will be useful. Often deriv-
atization alters the unit cell parameters in such a way that
the isomorphism is not maintained. It is not uncommon for
a lab to have a very nice native data set, but then spend
a good deal of effort defining good, useable, isomorphous
derivatives. Thus, even a diffracting crystal is not a guaran-
tee of immediate success.
A second phase determination method basically incor-
porates the heavy atom directly into the protein. This
requires the ability to overexpress the protein of interest
and to substitute the sulfur atoms of the methionine resi-
dues with selenium atoms. It also requires a tunable
X-ray source, generally provided by a synchrotron X-ray520 Neuron 54, May 24, 2007 ª2007 Elsevier Inc.beamline. The incorporation of selenium allows a special
type of experiment to be done in which data are collected
at the wavelength at which the selenium atoms absorb
X-rays as well as at wavelengths at which they do not.
This sort of experiment is known as a multiwavelength
anomalous dispersion or single wavelength anomalous
dispersion (MAD or SAD, respectively) (Dauter et al.,
2002; Dodson, 2003; Ealick, 2000). Differences in the in-
tensities of the reflections allow one to locate the selenium
atoms, just as similar differences allow the determination
of heavy atom positions. The advantage over MIR is that
the experiment can be done on a single crystal. MIR re-
quires multiple crystals, and frequently the treatment of
the crystals with the heavy atoms causes serious degra-
dation in the diffraction quality. This issue is completely
avoided with the MAD or SAD experiment.
Finally, the third common way to solve structures is by
molecular replacement. This method takes advantage of
the fact that the basic backbone architecture of many pro-
teins of interest are similar to proteins or protein domains
for which there are already high-resolution structures. For
example, a scientist might be interested in examining a se-
ries of mutations to see how they perturb a structure or to
see how drugs might bind and interact with a target. In
general, for such approaches to work, the target and the
model backbone atoms must be within 2.0 A˚ root
mean squared deviation (RMSD). Model bias can be an is-
sue, and generally, careful crystallographers use a number
of means to make sure that such issues are minimized.
Solving and Refining a Structure
Once the phase problem has been solved, the crystallog-
rapher is faced with what many regard as the most enjoy-
able part, which is building the structure into electron den-
sity maps. In my opinion, this exercise is the best way to
get a real sense for how proteins are put together. If the ini-
tial electron density maps are good, one can readily rec-
ognize protein structural features such as a helices,
b sheets, side chains, and cofactors (Figure 3C). The pro-
cedure involves matching the covalent structure of the
molecule (i.e., the protein sequence) with the density.
How easy or how hard this step is depends on the resolu-
tion to which the crystals yield good data. Different protein
structural features require different resolutions (Table 3).
The definition of individual atoms requires data at 1.5 A˚
resolution or better. At %2.0 A˚ resolution, the electron
density of individual side chains will be well enough re-
solved to define specific conformers. At 3.0 A˚ resolution
or lower, major structural features such as a helices and
b sheets are clearly distinguishable, but many side chains
may not be resolved. Moreover, the electron density map
may not be of uniform quality. Some parts of the protein
may be poorly ordered and not visible at all. With high-
resolution data (%2.0 A˚) interpretation is fairly straight-
forward. At lower resolutions, ambiguities may exist that
require multiple rounds of model building and refinement.
Either way, the basic procedure is a bootstrapping one
wherein atoms for the interpretable density are placed in
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unit); the positions are then refined against the data, new
maps are calculated using the new phase information
from the model, and the procedure is repeated (Figure 1,
step H). This iterative building and refinement process
gradually improves the phases and the quality of the
maps such that features that may not have been visible
at the outset become visible. In cases where the data
are%2.3 A˚, automated building and refinement programs
can do much of the work (Badger, 2003; Lamzin and Per-
rakis, 2000). At lower resolutions, the work still requires
building and map interpretation to be done by a human.
It should be noted that the precision of the placement of
the atoms in a macromolecular structure is typically
much greater than the resolution of the data. The posi-
tional errors in the core regions (i.e., those that are best
defined) range from 0.1–0.2 A˚ at 1.5 A˚ resolution to
0.5 A˚ at 3.0 A˚ resolution. Why is this precision better
than the diffraction limit? Chemistry. We know the average
lengths and angles for all of the types of covalent bonds
that hold together a protein. These values are included
as restraints in the refinement procedure and ensure that
the final structural model makes good chemical sense.
Given the self-reinforcing procedure of model building
and refinement, how can one be certain that the new
maps and refined structures are not simply the result of
ever-increasing model bias? Fortunately, the data from
an X-ray diffraction experiment are redundant to some de-
gree. Thus, one can actually exclude 5%–10% of the data
from the entire refinement procedure and use this set
(known as the Rfree set) as an unbiased metric of how cor-
rect the structure refinement is (Brunger, 1993). During the
structure refinement, the crystallographer compares how
well the structural model predicts the Rfree dataset. It is
Table 3. Rough Guide to the Resolution Required
for Identifying Features of Different Types in a
Well-Phased Electron Density Map of a Protein
Type of feature
Approximate
resolution
a helix 9 A˚
b sheet 4 A˚
‘‘random’’ main chain (i.e. no regular
secondary structure)
3.7 A˚
Aromatic side chains 3.5 A˚
Shaped bulbs of density for small
side chains
3.2 A˚
Interpretable conformations
for side chains
2.9 A˚
Density for main-chain carbonyl groups,
identifying plane of peptide bond
2.7 A˚
Ordered water molecules 2.7 A˚
Resolving individual atoms 1.5 A˚
Table is taken from Blow (2002).now routine to report the R and Rfree values for a crystal
structure. These two numbers serve as one metric for
how correctly things have been done. R and Rfree should
be similar (Rfree is always higher by 2%–6% for well-
refined structures). During the refinement process, the
value of R may decrease, but Rfree will stay the same (or in-
crease). If the R values are already low, this is one way for
crystallographers to know when to stop refining. Large dif-
ferences between R and Rfree indicate that some portion of
the model is incorrect and that something needs to be
corrected before the refinement can be completed. Exam-
ination of stereochemistry and Ramachandran analysis
provide two other good measures of the quality of a struc-
ture. In good structures, one should see RMSD for bond
lengths of <0.02 A˚ and bond angles of <2; curiously, lower
values than these do not necessary indicate higher quality
structures but may reflect the use of too-tight constraints
during refinement. Ramachandran analysis examines
which parts of conformational space the protein is in
(Kleywegt and Jones, 1996). Due to steric constraints,
the conformational space that the protein backbone can
sample is limited. Most of the model, if not all, should be
in the favored and allowed regions of a Ramachandran
plot. Significant numbers of amino acids in the ‘‘dis-
allowed’’ region are causes for concern.
Interpreting Structures
Although the process of structure solution may take a long
time from the inception of the project to a final refined
structure (anywhere from 1 month to multiple decades),
from many perspectives the final, refined structure is just
the very beginning of the investigation. At this stage, the
intersection of biochemistry, mutational studies, and func-
tional data with the structure becomes critical. When there
has been a good deal of prior mutagenesis and biochem-
ical work done on the crystallized protein or on a close
homolog, the structure provides a ready framework for
understanding prior observations and can immediately
reveal where binding sites, active sites, and distinct func-
tional domains lie. A beautiful example of this intersection
can be seen in the work on the snail acetylcholine binding
proteins (AChBPs) (Celie et al., 2004, 2005a, 2005b; Ulens
et al., 2006). These soluble proteins are homologs of the
extracellular neurotransmitter binding domain of nicotinic
acetylcholine receptors (nAChRs). The initial structure de-
termination revealed the conserved fold that is likely to be
found in the ligand binding domains of the entire receptor
family (Brejc et al., 2001). Good sequence correspon-
dence with nAChRs permitted the synthesis of decades
of research on this protein class with the ready identifica-
tion of the ligand binding site and the autoimmune binding
site associated with myasthenia gravis. Importantly, there
were key differences in the part of the protein that should
face the membrane. In AChBP, this part was composed of
hydrophilic amino acids, while the same region in the
intact receptor is largely hydrophobic. Subsequent cocrys-
tal structures with a number of ligands and peptide toxins
have further revealed the details about ligand selectivityNeuron 54, May 24, 2007 ª2007 Elsevier Inc. 521
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et al., 2005; Ulens et al., 2006).
Usually, there is only one major conformation of the pro-
tein in the crystal. This conformation provides a snapshot
of only one of the possible conformations that the folded
state of the protein may inhabit during its lifetime. While
no single structure can answer all questions about protein
function, structures have a great power to parse which
functional mechanisms are tenable and which are not.
For example, structure determination of the calcium chan-
nel b subunit alone and as a complex with its binding site
on the pore-forming subunit eliminated a long-standing
notion in the field regarding how these two subunits inter-
acted, defined the real high-affinity binding site, and re-
vealed the true nature of the interaction (Chen et al.,
2004; Opatowsky et al., 2004; Van Petegem et al., 2004).
It is always important to ask which conformational state
has been crystallized. Because of the nature of protein
crystals, it is not likely that, by virtue of the crystallization,
the protein has been ‘‘forced’’ into some conformation
that was not present in the crystallization solution. Cer-
tainly, there can be parts of the protein that can be af-
fected by crystal lattice contacts, but these effects tend
to be limited to particular conformations of surface resi-
dues or flexible regions. Nevertheless, it is essential to
get some context for the structure. In the best cases, trap-
ping the protein in a particular state with a substrate, sub-
strate analog, or inhibitor can do this. For proteins where
such reagents are not available, some mixture of muta-
tional analysis and biochemical or functional assay that
tests a mechanistic prediction of the structure will be use-
ful. Here is where the power of the structure becomes
manifest. Structures are fantastic platforms for hypothesis
generation as they enable the researcher to make precise,
testable predictions about function from an analysis of
which portions of the proteins are where, which interact
with what, and which might be key for a given function.
The recent debate over how exactly the voltage sensor
in voltage-gated potassium channels works illustrates
this issue nicely (Jiang et al., 2003; Lee et al., 2005; Tom-
bola et al., 2006). The original structure solution of the
archaeal voltage-gated potassium channel KvAP (Jiang
et al., 2003) revealed an unexpected conformation of the
voltage sensor (now thought to be a nonnative state
caused by lack of the constraints imposed by the lipid bi-
layer; Lee et al., 2005; Long et al., 2005). The possibility
that the voltage sensor conformation seen in the crystal,
or a closely related conformation, might actually occur in
a native membrane environment sparked a great deal of
structure-based functional tests that still have yet to pro-
vide a unified resolution (Tombola et al., 2006).
There are some basic properties that are easy to sort
out once a structure is known. Is the protein fold related
to other known structures? If so, which ones? The Dali
Server online is a useful tool for such questions and en-
ables one to readily generate superposition files of PDBs
so that one can compare the structures (http://www.ebi.
ac.uk/dali/). Which residues are on the surface? Do any522 Neuron 54, May 24, 2007 ª2007 Elsevier Inc.sit in interesting environments, such as an active site or
binding interface? Visual inspection of the protein struc-
ture is usually a good way to get at these questions.
By crystallizing a protein in different conformational
states, it may be possible to build up a molecular movie
of the structures and potential structural transitions that
occur as it performs its function. One of the most beautiful
examples of the power of such an approach is evident in
the recent structural work on the calcium ATPase from
skeletal muscle. This membrane protein uses ATP hydro-
lysis to drive protein conformational changes that trans-
port calcium ions from the cytoplasm into the sacroplas-
mic reticulum. Because there are a wide range of ATP
analogs for various steps in the hydrolysis reaction as
well as other pump inhibitors, it has been possible to de-
termine the structure of this pump in six out of eight states
from its reaction cycle, and to make a movie in which the
models of the crystallized states are connected by inter-
polation of conformational changes that only involve rea-
sonable rotations of bonds and domains (Toyoshima
et al., 2004). The resulting movie gives a breathtaking
view into the elegant inner workings of an ion pump.
Many ‘Easy’ Pieces?
It is a fortunate fact that proteins are highly modular. Biol-
ogy uses this property to create proteins with new func-
tions through mixing and matching individual domains.
Structural biologists exploit the modularity to isolate func-
tional domains that can be studied and characterized
structurally. This approach has been used to great effect
to study many ion channels and cell surface receptors.
The bonuses are obvious. The ability to get some struc-
tural information regarding a protein for which there was
previously none provides a major candle in the dark for ev-
eryone in the field, even if the candle does not illuminate
the entire landscape. Thus, the study of domains, which
is a well-established approach for both soluble and mem-
brane proteins, provides a timely and pragmatic way to
bring a problem from cartoon fantasy into 3D reality. If
the domain happens to bind a key ligand, as in the AChBP
example, it can serve as a ready template for examining
the details of ligand binding and specificity. What are the
limits? The structure of a fragment reveals nothing regard-
ing the absent parts of the protein, except for where cova-
lent connections to other domains might lie. For this rea-
son, the study of fragments demands that there be
some accompanying functional studies to test the limits
of the structural data so that it can be clear what is new
and what has yet to be discovered. However, one should
not assume that just because a structure is of an extra-
membranous portion of a channel or receptor that it was
trivially easy to determine or that by virtue of being a frag-
ment it is somehow uninteresting or uninformative.
Simulacra: Homology Models,
Interkingdom Inferences
It is not uncommon for structures of bacterial and archaeal
proteins to be used as stand-ins for interpreting data from
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to be determined in atomic detail. How much can we learn
from the structure of a protein that is similar to, but not ex-
actly, the one that we may study? The answer depends on
the details of the question asked. There is no doubt that
motifs of active sites and general protein architecture
have conserved architectural features that are preserved
throughout billions of years of evolution. Nevertheless,
even though the bacterial or archaeal proteins may serve
as good guides, it is unfortunately not yet possible to build
homology models with the accuracy needed to make de-
finitive statements about specific interactions (Petsko and
Ringe, 2003). The problem (or advantage) with proteins is
that they are able to absorb changes to the sequence by
altering their structure. Changes in side-chain properties
from one homolog to another can perturb the structure
in unforeseen ways, and while it may be a good bet that
the active site of a bacterial or archaeal channel or trans-
porter indicates something about the nature of a highly
conserved site in a mammalian counterpart, the level of
‘‘fuzziness’’ still remains high. Any homology model is in-
herently very biased toward the structure of the starting
template (Petsko and Ringe, 2003). As it stands now, the
best homology models get the backbone fold mostly cor-
rect. Precise positioning of side chains and loops remains
beyond our present reach. As protein sequences diverge
there may be judgment calls that need to be made to ob-
tain the proper correspondence between residues. Thus,
many of the things that a biologist might want to do with
a homology model are beyond what can be done reliably,
such as understanding the details of side-chain inter-
actions, docking proteins, or ligands. Nevertheless, even
a poor homology model can prove of some use for design-
ing the typical biological experiment, picking which resi-
due to mutate to test a hypothesis about function.
The ‘Static’ Nature of Crystal Structures
It is not really correct to claim that X-ray structures are
‘‘just static pictures’’ of macromolecules. Although the
final refined model represents the average positions of
the atoms, the structures do contain information about
the mobility of different parts (Furnham et al., 2006). One
indicator is something known as the B-factor. Each atom
in the structure has a B-factor value that describes the av-
erage mean displacement from the position seen in the
structure. As a general rule of thumb, low B-factors
show areas of low mobility and high B-factors show re-
gions of higher mobility. This simple interpretation can
break down in low-resolution structures (>2.7 A˚) as these
structures generally have higher average B-factors that
also reflect the general disorder in the lattice.
Regions that have multiple conformations may be
poorly defined or absent from the final refined models.
While absence of a region does not necessarily mean
that it is unstructured, it does indicate that the region in
question has multiple conformations that are not identical
in every copy of the macromolecule in the crystal lattice.
Even though large-scale motions of proteins are not al-lowed in a crystal (for example, oxygenation of hexagonal
crystals of deoxyhemoglobin famously caused the crys-
tals to crack, dissolve, and reform as needles containing
oxyhemoglobin [Haurowitz, 1938]), it has been shown
many times that enzymes are active in the crystalline state.
Thus, some small-scale motions must be permitted. While
structures represent one (or a limited set of) conforma-
tion(s), one should not mistake the ribbon diagram shown
in a publication for an indication that proteins are inflexi-
ble. The structure itself does not immediately reveal the
energetic importance of interactions or the inherent dy-
namics, but it can provide some very good clues for where
to look using other methods.
X-ray studies may involve a long, difficult path to obtain-
ing information about the structure of a macromolecule.
Nevertheless, the immense amount of information that
such studies reveal regarding molecular anatomy gives
an unparalleled vantage point for understanding functional
mechanisms and makes the endeavor most worthwhile.
Electron Microscopy
Not every protein or protein complex may be able to be
coaxed into a 3D crystal. In such cases, EM studies can
be a useful way to extract structural information (Hender-
son, 2004). Electron microscopy methods can image mol-
ecules as single particles (thus, bypassing the need for
a crystal), filaments, 2D crystals, and tubular crystals pos-
sessing helical symmetry (Chiu et al., 2005). The wave-
lengths of the electrons used are on the order of a fraction
of an angstrom, and as such, there is no inherent limit in
resolving the atomic structure of a macromolecule. Be-
cause it is possible to focus the electrons to form an image
in the electron microscope, EM studies also have an
advantage in that there is no phase problem. By examin-
ing single particles, one can skirt the problem of multiple
conformations, as long as one can recognize systematic
conformational differences between individual particles.
However, electrons have much more energy than the
X-rays used in a crystallographic experiment, and for
EM, radiation damage is an even more critical issue than
in X-ray experiments. As a result, low-dose and low-
temperature (liquid nitrogen or liquid helium) methods
must be used. Trying to achieve the balance between im-
aging and destroying the sample is the biggest challenge
and serves as a major limit to the resolution that can be
achieved. It remains a major feat to obtain EM structural
data at <9 A˚ resolution. Thus, the structural data that are
usually obtained reveal more about the basic shape or
domain structure of a protein or protein complex and
very little about the details.
One straightforward way to avoid the radiation damage
issue is to make a ‘‘negative stain’’ image of the protein
under study. In this experiment, a hydrophilic agent
(most commonly uranyl acetate) that does not bind pro-
teins is applied to the protein samples on the EM grid
(Kiselev et al., 1990). The resulting images show where
the stain is excluded and thereby define the protein enve-
lope. The limit to such studies is an 20 A˚ resolution.Neuron 54, May 24, 2007 ª2007 Elsevier Inc. 523
Neuron
PrimerThere can be issues if the protein has interior cavities that
bind the stain. While one cannot see many structural de-
tails at this resolution, the approach can be very powerful
when combined with high-resolution X-ray structures.
One recent example of this is the delineation, by EM, of
the conformational changes that happen to the ecto-
domains of cell surface receptor integrins, in which one
conformation was known at high resolution from X-ray
studies (Nishida et al., 2006). Because the conformational
changes could be controlled by the addition of ligands and
caused large domain rearrangements, it was possible to
understand how extension of the protein is intimately
linked with receptor activation. Similarly, recent studies
of AMPA receptor complexes by EM have suggested
how individual domains that have been solved by high-
resolution X-ray studies are arranged in the intact receptor
(Nakagawa et al., 2005). These studies together with other
work in the EM field make it clear that integrated studies
that merge X-ray structures with EM images are powerful
tools for understanding the conformational states of large
macromolecular machines and assemblies.
A second way that single-particle studies can be done,
which is also a method that can achieve higher resolution,
is to image the protein in ice using a method known as
cryo-EM (Chiu et al., 2005; Jiang and Ludtke, 2005). The
challenge with this approach is that there is poor contrast
between the protein and the ice. This issue, together with
the low-dose requirement to avoid sample destruction,
makes for very noisy raw data images. It is a major chal-
lenge to image proteins <250 kDa with this method.
Much of the research in cryo-EM remains focused on de-
veloping methods to extract the information from the very
noisy images (Chiu et al., 2005). Also, particle picking is
still not done by automation, although this is an area of in-
tensive methods development (Orlova and Saibil, 2004).
For large complexes, especially those with high internal
symmetry such as viruses, averaging methods can facili-
tate structure resolution (Jiang and Ludtke, 2005), and
a few thousand individual images of particles can be
enough to generate a structure at 10 A˚ resolution. For
objects with less symmetry, one to two orders of magni-
tude more images are required (Chiu et al., 2006).
In terms of single-particle reconstructions, it is actually
not straightforward to determine precisely the resolution
of the resultant density maps. A common way is to com-
pare two independent maps and determine the Fourier
shell correlation. There is no agreement for how to set
the cutoff (Chiu et al., 2005; Jiang and Ludtke, 2005;
Rosenthal and Henderson, 2003), so claims of resolution
should be taken with caution. Moreover, different parts
of the map may have better or worse resolution than
others due to domain flexibility, misalignment, or preferred
particle orientations. It is not the same as an X-ray exper-
iment, wherein the scientist knows where the data stop.
Also, it should be noted that there is no Rfree equivalent
for a single-particle reconstruction. Cross-validation is
done by splitting the data into two sets, doing two sepa-
rate reconstructions, and comparing. While this can pro-524 Neuron 54, May 24, 2007 ª2007 Elsevier Inc.vide some degree of confidence, there is yet no truly ob-
jective way to vet the structures.
Electron crystallography has been used to study mem-
brane proteins in their native environment, a lipid mem-
brane (Renault et al., 2006). As with X-ray crystallography,
electron crystallography requires an ordered array of pro-
teins, but instead of a 3D crystal, the array is either a 2D
sheet, or a hollow, helical tube (Mosser, 2001). Thus far,
the largest impact of this approach on neurobiological
questions has been made by Unwin and colleagues in
their work on imaging the open and closed states of the
nAChR (Miyazawa et al., 2003; Unwin, 1995). The advan-
tage of electron crystallography is that there is no phase
problem; one can take images of the crystals. The diffi-
culties arise in the fact that the crystals are never really
perfectly ordered. Because they are tubes or sheets that
are only one protein molecule thick, they are prone to
bending and buckling. Computational methods have
been developed to help overcome these issues (Berou-
khim and Unwin, 1997). The technical challenges of elec-
tron crystallography remain high, and there are still only
a few labs in the world that are expert. The promise of
imaging proteins in a membrane environment maintains
the enthusiasm for this approach and is expected to fuel
further developments in this field (Renault et al., 2006).
Finally, there is an emerging effort in combining X-ray
and cryo-EM studies (Fabiola and Chapman, 2005).
Here, the main challenges are developing robust methods
for assessing the correct placement of atomic models in
low-resolution EM maps. Such combined approaches, to-
gether with homology modeling, have recently led to the
publication of a complete molecular model for a clathrin
lattice (Fotin et al., 2004; Fotin et al., 2006). We can expect
that further work using similar approaches will help scien-
tists bridge the gap between large protein complexes that
can be imaged but not crystallized and high-resolution
models from X-ray work.
SAXS, an Old Dog with New Tricks
What if there were a method that could give you a 10–15 A˚
molecular envelope of density for a large structure in
a short period of time with modest effort? While such an
idea was once a structural biology dream, recent ad-
vances in both instrumentation and computation are
bringing a simple solution method known as SAXS into
the realm of possibility (Svergun and Koch, 2002, 2003).
The experiment is simple. One measures the 1D X-ray
scattering curve for a solution of purified protein sample
(at the concentrations that are usually used for crystalliza-
tion, or 5–30 mg ml1). The shape of the scattering curve
contains information about the size and shape of the mol-
ecules doing the scattering. While at first pass one might
think that such a curve might contain limited information,
with the advances in computational power it has become
possible to construct de novo models of the likely struc-
ture that might have produced the data. This is done by
using a collection of hard spheres that equal the number
of amino acids in the subject and defining arrangements
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(A) Top shows the ab initio model for SAXS data from the Kv4.3 T1 domain/KChIP1 complex calculated from the scattering data. The bottom panel
shows the scattering intensity profile for the data (black) and the model (red). (B) Comparison of the crystal structure of the Kv4.3 T1 domain/KChIP1
complex with the ab initio model shows excellent correlation with the data in contrast to an alternative square-shaped arrangement shown in (C).
The Dmax values show the maximal dimension of the particles calculated from the data (A) and from the models (B and C). Data are from Pioletti
et al. (2006).of the spheres that recapitulate the scattering profile
(Svergun et al., 2001) (Figure 4). This is an inherently
underdetermined problem, and many related configura-
tions of spheres could give equally good fits (imagine the
difference made by displacing just one ball to a new
position). The typical procedure is to run the calculation
multiple times, average the models, and examine the
features that are convergent. With good data one can
get a reliable estimate of the overall shape and dimensions
of the molecule.
The real power of SAXS is manifest when it is combined
with high-resolution models. SAXS is a terrific approach
for vetting competing models of multiprotein complexes
based on arrangements of X-ray crystallographically
determined domains. By calculating the SAXS profile of
different models (Svergun et al., 1995), the method canreadily eliminate certain arrangements. This sort of com-
bined approach has been used elegantly by the Kuriyan
lab to understand the conversion of inactive CaMKII to ac-
tive CaMKII (Rosenberg et al., 2005). My own lab has used
it to examine competing models for the assembly arrange-
ments of voltage-gated potassium channel regulatory do-
mains (Pioletti et al., 2006) (Figure 4). The requirements for
SAXS samples are similar to those used in crystallization.
As many synchrotrons now have SAXS beamlines, it
seems likely that many crystallographers will turn to
SAXS as an alternative means to get informative data
regarding the shape of their protein or to examine confor-
mational transitions. At the very least, if one’s crystals do
not diffract well, it should be possible to return from
a beamline trip with some data about the gross organiza-
tion of the molecule or complex under study.Neuron 54, May 24, 2007 ª2007 Elsevier Inc. 525
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Interaction Mapping
NMR spectroscopy can also be used to determine macro-
molecular structures in solution (Clore and Gronenborn,
1998; Ferentz and Wagner, 2000). The way that this is
done is completely different from the imaging methods
of X-ray crystallography and EM. Instead of imaging the
sample with incident radiation, the sample solution is
placed in a tube in a high-field magnet (500–800 MHz)
and irradiated with radio waves. Each NMR active nucleus
in the sample results in a peak at a characteristic fre-
quency in the spectrum. Each peak in the spectrum has
a position (relative to either the carrier frequency of the
magnet or an internal standard) known as the chemical
shift. The position of each peak corresponds to the partic-
ular energy that is required to flip the nucleus of the atom
between states that are aligned parallel or antiparallel to
the strong external magnetic field provided by the instru-
ment and is exquisitely sensitive to the local magnetic en-
vironment of the atom. Proton nuclei are NMR active (nat-
ural abundance is 99.98%) (Wu¨thrich, 1986), and because
of their ubiquity in proteins, they provide a great source of
residue-by-residue information. In proteins >10 kDa,
spectral overlap becomes a problem for proton-only
NMR. To increase the spectral resolution so that reso-
nances with similar chemical shifts can be resolved re-
quires doing experiments that use 1H, 15N, and 13C nuclei.
However, the natural abundance of the NMR active iso-
topes for the carbon and nitrogen are too low to be of gen-
eral use in macromolecular samples (1.11% and 0.37%,
respectively) (Wu¨thrich, 1986). Fortunately, by using ex-
pression systems one can label the carbon and nitrogen
atoms (either uniformly or selectively, depending on the
approach) with 13C and 15N by supplementing the growth
media (Goto and Kay, 2000). Another necessary modifica-
tion for proteins >25 kDa is to replace some of the cova-
lently bonded hydrogens with deuterium (Ferentz and
Wagner, 2000). This modification offsets the loss in signal
that occurs due to the greater number of relaxation pro-
cesses that accompany increased protein size. These
modifications do not perturb the structure and greatly ex-
pand the power of the NMR experiments (Ferentz and
Wagner, 2000).
Given an NMR spectrum, the spectroscopist must as-
sign each peak in a spectrum to a particular atom in the
protein. Information is gathered from a variety of different
types of experiments that determine which atoms are
close to each other by virtue of covalent interactions,
what the bond torsional angles are, and which atoms are
close (%5 A˚) because of the overall 3D structure of the
macromolecule (Clore and Gronenborn, 1998; Ferentz
and Wagner, 2000). Additional structural information can
be derived by exploiting recently developed methods for
weakly orienting the sample in solution to collect con-
formational restraints that define the orientation of certain
interbond vectors such as that between an amide proton
and nitrogen atom (Bax and Grishaev, 2005). In any
NMR structure calculation, it is necessary to include other526 Neuron 54, May 24, 2007 ª2007 Elsevier Inc.constraints such as covalent constraints for bond lengths
and geometries along with explicit potentials for non-
bonded interactions (Clore and Schwieters, 2002). Once
the spectra have been assigned (i.e., the atom belonging
to each peak is known), the spectroscopist uses all the
constraints that can be measured plus the bond con-
straints to build atomic models that are consistent with
the data. A 2D analogy of the process is building a map
of a country from knowledge of the distances between
all of the main centers of population. There are many
more details regarding the types of structural information
that can be gained from NMR. I encourage the interested
reader to refer to the recent excellent review by Ferentz
and Wagner (2000).
One of the major limits with solution NMR studies re-
mains the fact that there are issues with collecting usable
spectra for structure determination of proteins and protein
complexes >40 kDa (Tugarinov et al., 2004). This limitation
has confined the impact of macromolecular NMR in neu-
roscience to the determination of the structures of small
peptide toxins. There are serious efforts underway to
break through the size limitation so that large protein com-
plexes can be studied, but such studies are really at the
frontier of the method (Tzakos et al., 2006).
NMR can also be used to examine the structure of small
membrane proteins in the solid state such as the environ-
ment provided by a membrane (Luca et al., 2003; Mc-
Dermott, 2004). The sample requirements remain de-
manding, as 15N and 13C isotopic labeling is absolutely
required. The field is growing rapidly and the methodology
can be of particular use with samples that are recalcitrant
to crystallization. Solid state NMR has been used to define
the structure of a number of small transmembrane pep-
tides, but has not yet been used to determine the structure
of a membrane protein (Hong, 2006).
Because of the sensitivity to local environment, chemi-
cal shift is an excellent reporter of conformational changes
and intermolecular interactions between proteins or pro-
teins and small molecules (Carlomagno, 2005; Pellecchia,
2005; Takeuchi and Wagner, 2006). One very nice recent
synthesis of such methods with solid state NMR has
been employed in an examination of the conformational
changes in a potassium channel selectivity filter caused
by binding to a small, inhibitory peptide toxin (Lange
et al., 2006). This work is a good example of the power
of NMR methods to characterize protein-protein or pro-
tein-small molecule interactions in the context of a struc-
tural framework that has been provided by X-ray methods
and provides a view of toxin-channel interactions that has
thus far eluded crystallographic characterization. Ques-
tions about protein-protein and protein-small molecule in-
teractions drive much of basic molecular neuroscience
and the desire to develop new ways to control neuronal
activity. As the catalog of X-ray structures of channels,
transporters, and receptors grows, we can anticipate
a burgeoning number of studies that merge NMR and
X-ray structural data to characterize known interacting
partners and discover new ones.
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Molecular Sizing
Some of the most basic questions about macromolecular
structure are questions about assembly states. To answer
such questions, one does not need to solve a high-resolu-
tion structure but rather can employ a number of different
solution-based biophysical tools. The simplest is size-
exclusion chromatography. In this method the sample is
applied to a column that is packed with beads that have
a defined pore size. One monitors the elution time it takes
for the protein of interest to migrate through the column
(usually by ultraviolet absorbance). Because of the nature
of the pore sizes in the column, large proteins have limited
access to the internal pores of the bead, and thus elute
first. Smaller proteins have access to the internal pores
and meander through them, thereby making their passage
time through the column longer. Molecular biologists
should note that this is the exact oppositemigration profile
from passage through continuous media such as an aga-
rose or acrylamide gel. An analogy for size-exclusion
would be a comparison of the time it takes for adults ver-
sus children to cross a playground. Adults will not fit on
most of the equipment, and thus can cross from one
side to the other without diversion. The same is not true
for the children. Estimation of molecular weight by size-
exclusion chromatography requires a comparison with
a standard curve using protein standards of known molec-
ular weight. It should be noted that interpretation of the
molecular size of the test protein could be confounded
by unusual protein shape, the presence of detergent mi-
celles, and interactions with the column matrix. Thus,
while size-exclusion chromatography is useful, because
what it actually measures is an effective hydrodynamic ra-
dius, it is not a definitive measure of absolute molecular
size.
One of the best unbiased ways to measure molecular
size is equilibrium analytical ultracentrifugation. This ex-
periment pits the centripetal force generated by a centri-
fuge against buoyancy. Special cells are used that allow
the experimentalist to monitor protein concentration as
a function of radial position (usually by UV absorbance).
Spinning the rotor creates a gradient of protein across
the cell. Once the system is at equilibrium (i.e., the distri-
bution of the material across the cell no longer changes)
one measures the radial distribution of macromolecules.
By knowing the amino acid composition of the protein,
the components of the solution, temperature, and rotor
speed, one can explicitly solve a set of equations that
yields the molecular mass. This experiment is indepen-
dent of shape and size considerations. For self-associat-
ing systems, the experiment can also be used to measure
affinities. The work by Gouaux and colleagues provides
a nice example of the power of this experiment to sort
out an ion channel gating mechanism when paired with
structural and functional data (Sun et al., 2002). In this
case, the authors used analytical ultracentrifugation to es-
tablish that two ways of blocking receptor desensitization,
a well-studied channel mutation and a drug, acted by sta-bilizing the formation of dimers between receptor extra-
cellular domains. These observations combined with elec-
trophysiological and crystallographic studies provided
evidence for the importance of conformational changes
at the receptor extracellular domain interfaces in receptor
activation and desensitization.
Binding Interactions
Binding events are of central importance in the function of
macromolecular machines and signaling networks. Un-
derstanding the nature of interactions between members
of macromolecular complexes is an important step in un-
derstanding function and critical for the development of
selective inhibitors. There are many different ways to mea-
sure binding. In the discussion about NMR I mentioned
one structural approach to characterizing interactions.
Here, I would like to highlight a second biophysical
method that is gaining prominence for understanding the
details of binding energetics but is likely to be unfamiliar
to a neurobiologist, isothermal titration calorimetry (ITC)
paired with alanine scanning mutagenesis.
Calorimetry: Feeling the Heat. Elementary thermo-
dynamic considerations state that all reactions must pro-
ceed with a change in energy that either removes or gives
off heat to the surroundings. The ITC experiment directly
measures the evolution or uptake of heat when two com-
ponents are mixed (Leavitt and Freire, 2001; Velazquez
Campoy and Freire, 2005). The setup of the experiment
is conceptually simple. A thermostated chamber is filled
with one of the components. A titration syringe adds de-
fined volumes of the other component into the chamber
under mixing conditions. If the two components interact,
heat will be absorbed or evolved. By virtue of a feedback
mechanism, which should be familiar to anyone who has
ever done a voltage-clamp experiment, the instrument
measures how much current is required to maintain the re-
action chamber at a constant temperature. This provides
a direct measure of the heat of the reaction. The advan-
tage of ITC is that it is the only method that directly mea-
sures the thermodynamic parameters of binding. Also, it is
a high-resolution method, meaning that binding events
that may have been silent if probed by some other method
that relies on an intermediary for detection can be seen.
The effective range of the measurement encompasses
binding reactions having association constants of 104 <
Ka < 108 (Velazquez Campoy and Freire, 2005).
Binding interfaces in protein-protein interactions are
usually large (600–2000 A˚2) and may involve intermolecu-
lar contacts from 10 to 50 side chains from each protein
(Lo Conte et al., 1999; Nooren and Thornton, 2003). One
thing that cannot be discerned from any structural method
is the relative importance of individual interactions. One of
the increasingly common approaches is to combine struc-
tural data, ITC, and a mutagenesis method known as
alanine scanning mutagenesis to probe protein-protein
or protein-ligand interaction surfaces. Alanine scanning
mutagenesis takes each residue that contributes to an in-
terface and changes it to alanine (Wells, 1991). Because
alanine has the common core that is shared by all aminoNeuron 54, May 24, 2007 ª2007 Elsevier Inc. 527
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whether an individual side chain contributes positively,
negatively, or not at all to the energy of binding. The com-
mon result seen thus far is that even though protein-
protein or protein-ligand interfaces are large, there is
only a limited set of interactions that dominates the ener-
getics (Arkin and Wells, 2004; Clackson and Wells, 1995;
Desrosiers and Peng, 2005). Why is this a useful thing to
know? Such clarification is essential for designing ways
to disrupt the interaction, whether that is to maximize
the impact of mutagenesis in a functional study or to
achieve the ultimate design of small molecules that can
be used as research tools or even drugs (Arkin and Wells,
2004).
Dynamics
The role of time in living systems is one of the most
difficult, yet essential, things to understand. Macromole-
cules come to life because they undergo constrained
vibrations that result from thermal energy. How can we
understand motions based on the structures? Determin-
ing the structure of a protein in different conformational
states provides an essential guide but still does not reveal
how the protein might behave on the microsecond to mil-
lisecond timescales where many conformational reactions
take place. The best structural biology tool for measuring
macromolecular motions is NMR. Under the right experi-
mental circumstances, it can give atom-by-atom informa-
tion on the dynamic properties of a macromolecule (Kay,
2005; Mittermaier and Kay, 2006). Depending on the par-
ticulars of the experimental setup, it is possible to access
information about a broad range of timescales for back-
bone and side-chain motions (picoseconds to millisec-
onds). NMR dynamic studies are particularly powerful
when there is a high-resolution structure of the macromol-
ecule under study, and they make X-ray studies and
NMR highly complementary approaches to understanding
macromolecules. As with other NMR approaches, there
are still challenges in imaging large macromolecules
(>40 kDa). Nevertheless, the frontiers of the method are
constantly being pushed, enabling us to study larger and
more complicated systems (Kay, 2005).
Examples of NMR dynamics studies of channels and re-
ceptors are still limited but are illustrative of the insights
gained from the approach. Recent NMR studies of KcsA
in detergent micelles have given the first direct measure
of the dynamics of a channel selectivity filter (Chill et al.,
2006a, 2006b) and have shown key differences in the dy-
namic behavior of the transmembrane versus intracellular
domains (Chill et al., 2006a). Studies of the dynamic prop-
erties of different AMPA receptor agonists bound to the li-
gand binding domain suggest that although the X-ray
structures of the complexes are all similar, there are signif-
icant differences in how the protein dynamics are affected
by the ligands (Valentine and Palmer, 2005). Certainly, as
the field grows and more high-resolution structures are
solved, the combined power of NMR dynamics studies in-
terpreted in the context of structural framework will be felt
more and more.528 Neuron 54, May 24, 2007 ª2007 Elsevier Inc.Molecular Dynamics
It is unlikely that even the best experimental approach can
give structural information for every intermediate state for
every atom in the system as the protein moves from one
conformation to another. The main hope for understand-
ing how systems move through the transitions from one
state to the next is computer simulation and an approach
known as MD (Gumbart et al., 2005; Karplus and McCam-
mon, 2002). This computational approach attempts to
solve Newton’s equations of motion for all of the atoms
in a defined system given the constraints of the potentials
that represent the main sources of interaction and repul-
sion, for example, electrostatic and van der Waals interac-
tions. For a 100 residue protein (15 kDa), that amounts
to 2000 atoms, excluding the water. In the case of
a membrane protein where one needs to simulate the
protein, lipid bilayer, and water, even the smallest sys-
tem contains 50,000 atoms (Gumbart et al., 2005),
a formidable number of things to keep track of during
the simulation.
One of the major difficulties in obtaining great insights
from MD is that there remains a serious timescale gap be-
tween the timescale of simulations that can be run using
a reasonable amount of computational power (1–5 ns)
and the timescales at which protein motions that are rele-
vant for most functions occur (microsecond to second)
(Tama and Brooks, 2006). Additionally, the potentials
used to describe certain interactions remain an imperfect
description of the intermolecular forces. Moreover, the
study of a single molecule can have some strange con-
sequences. The energy landscapes that define protein
movements are rugged and may contain long-lived con-
formations that are kinetically trapped. To get a picture
of a rugged energy landscape, imagine being at the
peak of a large mountain at a big ski resort. There are
many paths leading down the mountain. It is easy to follow
a path to a place where one cannot descend further. How-
ever, the inability to descend does not guarantee that one
has reached global minimum of the base lodge; rather,
one may be stuck in a local minimum such as small,
high-altitude valley. In such a case, the only way to get
down to the base lodge is to return to the peak and follow
a different path of descent. Likewise, one would like to be
able to run the same simulation multiple times to see if the
protein always moves in the same way or sometimes
moves in different paths, and how many times and in
what conformations it is prone to spend the most time.
In processes where the timescale of the computation
matches the timescale of the physical event under study,
computational studies have been extremely revealing.
One such class of examples includes studies of ion per-
meation of channels (Roux, 2005). For ion permeation,
the physical process occurs on the timescale of nanosec-
onds and is well matched to the lengths of simulation
times that are presently feasible for systems that include
modestly sized proteins, water, ions, and a lipid bilayer
(tens of nanoseconds). Based on the successes here,
we can anticipate that with increases in computational
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such that longer timescale processes can be accurately
simulated.
One promising way, still being developed, to extend the
effective timescale of simulation is to use coarser grained
models in which only a limited set of the atoms are used to
do normal mode analysis (Tama and Brooks, 2006).
Coarse-grained studies make approximations by using
a reduced model with fewer atoms. Small groups of atoms
are treated as single particles. This allows one to run the
simulations longer and to have the ability to repeat the cal-
culation multiple times. In recent work studying the stabil-
ity of the isolated KvAP S4 voltage sensor in membranes,
the Sansom group found two distinct types of preferred
orientations, inserted into the bilayer and parallel to the bi-
layer surface (Bond and Sansom, 2007). The observation
of very different final outcomes from the same starting
point in the simulation underscores the importance of be-
ing able to map the robustness of MD trajectories and sug-
gests that coarse-grained studies may offer a good way to
explore conformational dynamics of different systems.
Finale and Future: Integrated Studies,
the Way Forward
All of the approaches presented here offer powerful ways
to gain authentic molecular insight into the anatomy that
underlies how macromolecules function. The impact of
these approaches is just starting to touch questions key
to understanding the nervous system. Where will these
detailed studies lead? Besides the explanatory power of
the various structural approaches for understanding mac-
romolecule function, they also offer templates for protein
design, the engineering of variants with novel function,
and the potential for providing powerful guidance for
drug discovery and development. As many of the ap-
proaches offer complimentary information, integrated
studies that use multiple methods to get at different levels
of structural questions offer a great advantage for query-
ing the nature of large macromolecular complexes in
different functional states. We can expect that such
approaches should eventually be applied to many types
of ion channels, transporters, receptors, and higher order
signaling complexes that include these components.
There is no question that such a bounty of molecular infor-
mation will bring new ideas of how macromolecules in
neurons function on their own and as components in sig-
naling networks. The advent of molecular structural neuro-
science has brought a thrilling start to understanding the
workings of the brain at a level that would make Ramon
y Cajal very proud of those following his legacy.
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